lexiara

10.

Each year the sponsor shall submit to the Agency a report on the state of development of the designated medicinal product.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-21 · Text as adopted (Official Journal); later amendments are not incorporated in this text.